Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02459457

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

Stage III Esophageal Squamous Cell Carcinoma Clinical Trial

Official title:
A Comparison of Paclitaxel in Combination With Cisplatin(TP), Carboplatin(TC) or Fluorouracil(TF) Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Squamous Cell Carcinoma: A Three-Arm Randomized Phase III Trial

Clinical Trial Summary

The purpose of this study is to determined the best scheme in paclitaxel and cisplatin，paclitaxel and fluorouracil，paclitaxel and carboplatin concurrent with radiotherapy for patients with local advanced esophageal Squamous Cell Carcinoma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02459457
Study type Interventional
Source Fudan University
Contact
Status Completed
Phase Phase 3
Start date July 1, 2015
Completion date February 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02628665 - Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer Phase 3
Recruiting NCT02607540 - Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer Phase 3
Recruiting NCT02603159 - Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy Phase 3
Recruiting NCT02604615 - The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy Phase 3
Active, not recruiting NCT02025036 - Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer Phase 3
Completed NCT02644408 - Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy Phase 3
Recruiting NCT02812641 - Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC Phase 2